Willheim M, Thien R, Schrattbauer K, Bajna E, Holub M, Gruber R, Baier K, Pietschmann P, Reinisch W, Scheiner O, Peterlik M
Institute of General and Experimental Pathology, Clinic of Internal Medicine IV, University of Vienna, Austria.
J Clin Endocrinol Metab. 1999 Oct;84(10):3739-44. doi: 10.1210/jcem.84.10.6054.
We studied the possible regulatory effects of 1alpha,25-dihydroxyvitamin D3 [1alpha,25-(OH)2D3] on cytokine production and differentiation of subsets of CD4+ [T helper 1 (Th1) and Th2] and CD8+ [T cytotoxic 1 (Tc1) and Tc2] lymphocytes at the single cell level. PBMC from healthy donors were cultured with or without 1alpha,25-(OH)2D3 for up to 21 days. On days 0, 7, 14, and 21, the percentage of cytokine-producing T lymphocytes was analyzed by intracellular cytokine detection with mAb and flow cytometry. Simultaneous staining for cell surface markers allowed discrimination of CD4+ and CD8+ T cell subsets. After culture with 1alpha,25-(OH)2D3 (10(-8) mol/L), no significant effects on the proportion of interferon-gamma (IFNgamma)- or interleukin-4 (IL-4)-producing cells were detected, whereas reduced frequencies of IL-2-producing cells in the CD4+ as well as in the CD8+ population were found. An increase in the low percentage of CD4+ and CD8+ T cells producing the Th2 cytokine IL-13 was noticed. Most interestingly, IL-6-producing CD4+ and CD8+ T cells could only be detected in cultures with 1alpha,25-(OH)2D3, reaching a plateau after 14 days. The percentage of IL-6-producing T cells induced by 1alpha,25-(OH)2D3 after a given time period remained stable for at least 7 weeks. Studies of cytokine coexpression revealed that about 70% of IL-6-producing CD4+ and CD8+ cells were also positive for IL-2, but more than 90% were negative for IFNgamma, IL-4, or IL-13, respectively. This suggests that the IL-6-producing population does not match the Th1/Tc1-like (IFNgamma+) or Th2/Tc2-like (IL-4+ or IL-13+) subset. The influence of 1alpha,25-(OH)2D3 on cytokine production by lymphocytes is probably an important point of intersection between the endocrine and the immune system.
我们在单细胞水平研究了1α,25 - 二羟基维生素D3[1α,25 - (OH)2D3]对细胞因子产生以及CD4 + [辅助性T细胞1(Th1)和Th2]和CD8 + [细胞毒性T细胞1(Tc1)和Tc2]淋巴细胞亚群分化的潜在调节作用。将来自健康供体的外周血单核细胞(PBMC)在有或无1α,25 - (OH)2D3存在的情况下培养长达21天。在第0、7、14和21天,通过用单克隆抗体进行细胞内细胞因子检测和流式细胞术分析产生细胞因子的T淋巴细胞的百分比。同时对细胞表面标志物进行染色可区分CD4 +和CD8 + T细胞亚群。在用1α,25 - (OH)2D3(10(-8)mol/L)培养后,未检测到对产生干扰素 - γ(IFNγ)或白细胞介素 - 4(IL - 4)的细胞比例有显著影响,而在CD4 +以及CD8 +群体中发现产生IL -
2的细胞频率降低。注意到产生Th2细胞因子IL - 13的CD4 +和CD8 + T细胞的低百分比有所增加。最有趣的是,仅在含有1α,25 - (OH)2D3的培养物中检测到产生IL - 6的CD4 +和CD8 + T细胞,14天后达到平台期。在给定时间段后由1α,25 - (OH)2D3诱导的产生IL - 6的T细胞百分比至少7周保持稳定。细胞因子共表达研究表明,约70%产生IL - 6的CD4 +和CD8 +细胞也呈IL - 2阳性,但分别超过90%对IFNγ、IL - 4或IL - 13呈阴性。这表明产生IL - 6的细胞群体与Th1/Tc1样(IFNγ +)或Th2/Tc2样(IL - 4 +或IL - 13 +)亚群不匹配。1α,25 - (OH)2D3对淋巴细胞产生细胞因子的影响可能是内分泌系统和免疫系统之间的一个重要交叉点。